144 related articles for article (PubMed ID: 29167182)
1.
Asprino PF; Linck RDM; Cesar J; Freitas FP; Koyama FC; Riechelmann RSP; Costa FP; Hoff PMG; Galante PAF; Meyer D; Camargo AA; Sabbaga J
Endocr Relat Cancer; 2018 Feb; 25(2):L1-L5. PubMed ID: 29167182
[No Abstract] [Full Text] [Related]
2. Pancreatic neuroendocrine tumor in a patient with a TSC1 variant: case report and review of the literature.
Mortaji P; Morris KT; Samedi V; Eberhardt S; Ryan S
Fam Cancer; 2018 Apr; 17(2):275-280. PubMed ID: 28887784
[TBL] [Abstract][Full Text] [Related]
3. Successful mTOR inhibitor therapy for a metastastic neuroendocrine tumour in a patient with a germline TSC2 mutation.
Schrader J; Henes FO; Perez D; Burdak-Rothkamm S; Stein A; Izbicki JR; Lohse AW
Ann Oncol; 2017 Apr; 28(4):904-905. PubMed ID: 28327903
[No Abstract] [Full Text] [Related]
4. [Associated gastroenteropancreatic neuroendocrine tumours to familiar syndromes].
Lecumberri Pascual E
Endocrinol Nutr; 2009 Apr; 56 Suppl 2():10-5. PubMed ID: 19627764
[TBL] [Abstract][Full Text] [Related]
5. ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas.
Garcia-Carbonero R; Sorbye H; Baudin E; Raymond E; Wiedenmann B; Niederle B; Sedlackova E; Toumpanakis C; Anlauf M; Cwikla JB; Caplin M; O'Toole D; Perren A;
Neuroendocrinology; 2016; 103(2):186-94. PubMed ID: 26731334
[No Abstract] [Full Text] [Related]
6. A pediatric case of osteosarcoma and tuberous sclerosis complex with a novel germline mutation in the TSC2 gene and a somatic mutation in the TP53 gene.
Kuroda K; Moriya K; Nakano T; Saito R; Sato D; Katayama S; Niizuma H; Watanuki M; Uematsu M; Sasahara Y; Kure S
Pediatr Blood Cancer; 2021 Jun; 68(6):e28960. PubMed ID: 33694273
[No Abstract] [Full Text] [Related]
7. Immunohistochemically Detected Expression of ATRX, TSC2, and PTEN Predicts Clinical Outcomes in Patients With Grade 1 and 2 Pancreatic Neuroendocrine Tumors.
Uemura J; Okano K; Oshima M; Suto H; Ando Y; Kumamoto K; Kadota K; Ichihara S; Kokudo Y; Maeba T; Nanno Y; Toyama H; Takada Y; Shimada M; Hanazaki K; Masaki T; Suzuki Y
Ann Surg; 2021 Dec; 274(6):e949-e956. PubMed ID: 31599805
[TBL] [Abstract][Full Text] [Related]
8. Signaling networks and the feasibility of computational analysis in gastroenteropancreatic neuroendocrine tumors.
Chen P; Wang Q; Xie J; Kwok HF
Semin Cancer Biol; 2019 Oct; 58():80-89. PubMed ID: 31054326
[TBL] [Abstract][Full Text] [Related]
9. A novel germline mutation at exon 10 of MEN1 gene: a clinical survey and positive genotype-phenotype analysis of a MEN1 Italian family, including monozygotic twins.
Palermo A; Capoluongo E; Del Toro R; Manfrini S; Pozzilli P; Maggi D; Defeudis G; Pantano F; Coppola R; Di Matteo FM; Raffaelli M; Concolino P; Falchetti A
Hormones (Athens); 2018 Sep; 17(3):427-435. PubMed ID: 30083881
[TBL] [Abstract][Full Text] [Related]
10. Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors.
Park C; Ha SY; Kim ST; Kim HC; Heo JS; Park YS; Lauwers G; Lee J; Kim KM
Oncotarget; 2016 Jan; 7(4):4024-35. PubMed ID: 26684240
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic neuroendocrine tumors in patients with tuberous sclerosis complex.
Larson AM; Hedgire SS; Deshpande V; Stemmer-Rachamimov AO; Harisinghani MG; Ferrone CR; Shah U; Thiele EA
Clin Genet; 2012 Dec; 82(6):558-63. PubMed ID: 22035404
[TBL] [Abstract][Full Text] [Related]
12. Detection of Somatic Mutations in Gastroenteropancreatic Neuroendocrine Tumors Using Targeted Deep Sequencing.
Backman S; Norlén O; Eriksson B; Skogseid B; Stålberg P; Crona J
Anticancer Res; 2017 Feb; 37(2):705-712. PubMed ID: 28179320
[TBL] [Abstract][Full Text] [Related]
13. [Genetic profile of gastroenteropancreatic neuroendocrine tumors].
Cabezas Agrícola JM
Endocrinol Nutr; 2009 Apr; 56 Suppl 2():16-9. PubMed ID: 19627765
[TBL] [Abstract][Full Text] [Related]
14. DNA methyltransferases 1, 3a, and 3b overexpression and clinical significance in gastroenteropancreatic neuroendocrine tumors.
Rahman MM; Qian ZR; Wang EL; Yoshimoto K; Nakasono M; Sultana R; Yoshida T; Hayashi T; Haba R; Ishida M; Okabe H; Sano T
Hum Pathol; 2010 Aug; 41(8):1069-78. PubMed ID: 20381114
[TBL] [Abstract][Full Text] [Related]
15. Gastroenteropancreatic neuroendocrine neoplasms: genes, therapies and models.
Kawasaki K; Fujii M; Sato T
Dis Model Mech; 2018 Feb; 11(2):. PubMed ID: 29590641
[TBL] [Abstract][Full Text] [Related]
16. Molecular and cell biological aspects of neuroendocrine tumors of the gastroenteropancreatic system.
Wiedenmann B; John M; Ahnert-Hilger G; Riecken EO
J Mol Med (Berl); 1998 Aug; 76(9):637-47. PubMed ID: 9725766
[TBL] [Abstract][Full Text] [Related]
17. Two novel mutations in the TSC2 gene causing severe phenotype in nervous system and skin in a patient with tuberous sclerosis complex.
Cammarata-Scalisi F; Vidales Moreno C; Stock F; Avendaño A; Araque D; Lacruz-Rengel MA; Diociaiuti A; Bellacchio E; Callea M
J Eur Acad Dermatol Venereol; 2018 Jun; 32(6):e243-e245. PubMed ID: 29265517
[No Abstract] [Full Text] [Related]
18. A Comprehensive Assessment of the Role of miRNAs as Biomarkers in Gastroenteropancreatic Neuroendocrine Tumors.
Malczewska A; Kidd M; Matar S; Kos-Kudla B; Modlin IM
Neuroendocrinology; 2018; 107(1):73-90. PubMed ID: 29566385
[TBL] [Abstract][Full Text] [Related]
19. Glutaminases in slowly proliferating gastroenteropancreatic neuroendocrine neoplasms/tumors (GEP-NETs): Selective overexpression of mRNA coding for the KGA isoform.
Szeliga M; Ćwikła J; Obara-Michlewska M; Cichocki A; Albrecht J
Exp Mol Pathol; 2016 Feb; 100(1):74-8. PubMed ID: 26581715
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation profiles distinguish different subtypes of gastroenteropancreatic neuroendocrine tumors.
How-Kit A; Dejeux E; Dousset B; Renault V; Baudry M; Terris B; Tost J
Epigenomics; 2015; 7(8):1245-58. PubMed ID: 26360914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
